Virtual Medicinal Product (VMP) - Etamsylate 250mg/2ml solution for injection ampoules
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Etamsylate 250mg/2ml solution for injection ampoules | Start Date 20-05-2004 | End Date |
| Previous Name | Previous Name Etamsylate 125mg/ml injection 2ml ampoules | Start Date 10-07-2003 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Intravenous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular, solutioninjection.intravenous
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- B02BX01
- BNF Codes
-
- BNF code 02110000
| Code | Start Date | End Date |
|---|---|---|
| 4671611000001107 | 10-07-2003 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Etamsylate | Based on Ingredient Substance | 125 mg | 1 ml |
Name
Etamsylate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
125.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMEtamsylate
-
VMP(Current) Etamsylate 250mg/2ml solution for in...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ampoule | ||
| 10 ampoule |